Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 65,150,667
- Share change
- -4,597,299
- Total reported value
- $951,174,601
- Put/Call ratio
- 82%
- Price per share
- $14.60
- Number of holders
- 155
- Value change
- -$110,130,293
- Number of buys
- 80
- Number of sells
- 80
Report period
Q3 2020
Institutions
155
Top holders
10
KPTI full security history
Newer quarter: Q4 2020
Previous quarter: Q2 2020
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
|
Company |
31%
|
7,000,000
|
$132,580,000 | — | 30 Jun 2020 | |
| Consonance Capital Management LP |
13F
|
Company |
29%
|
6,491,812
|
$122,955,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
28%
|
6,388,662
|
$121,002,000 | — | 30 Jun 2020 | |
| STATE STREET CORP |
13F
|
Company |
20%
|
4,598,947
|
$87,104,000 | — | 30 Jun 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
19%
|
4,219,452
|
$79,916,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
3,564,005
|
$67,501,000 | — | 30 Jun 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
14%
|
3,248,739
|
$61,531,000 | — | 30 Jun 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
13%
|
2,975,015
|
$56,347,000 | — | 30 Jun 2020 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
12%
|
2,790,501
|
$52,852,000 | — | 30 Jun 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.1%
|
2,064,900
|
$39,110,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
8.8%
|
2,000,078
|
$37,881,000 | — | 30 Jun 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.7%
|
1,961,580
|
$37,152,000 | — | 30 Jun 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.6%
|
1,502,501
|
$28,458,000 | — | 30 Jun 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.9%
|
1,335,000
|
$25,285,000 | — | 30 Jun 2020 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
5.5%
|
1,244,211
|
$23,565,000 | — | 30 Jun 2020 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
4.6%
|
1,036,947
|
$19,640,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
1,032,592
|
$19,557,000 | — | 30 Jun 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
4.4%
|
1,007,367
|
$19,080,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4%
|
903,500
|
$17,112,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4%
|
902,581
|
$17,095,000 | — | 30 Jun 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.4%
|
780,850
|
$14,787,000 | — | 30 Jun 2020 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
3.4%
|
761,819
|
$14,429,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
3%
|
675,410
|
$12,792,000 | — | 30 Jun 2020 | |
| Fairmount Funds Management LLC |
13F
|
Company |
2.9%
|
652,351
|
$12,356,000 | — | 30 Jun 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2.4%
|
554,374
|
$10,500,000 | — | 30 Jun 2020 | |
| Woodline Partners LP |
13F
|
Company |
2%
|
463,235
|
$8,774,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2%
|
443,721
|
$8,405,000 | — | 30 Jun 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.9%
|
438,081
|
$8,297,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.9%
|
422,746
|
$8,006,000 | — | 30 Jun 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.7%
|
392,831
|
$7,440,000 | — | 30 Jun 2020 | |
| Atom Investors LP |
13F
|
Company |
1.7%
|
389,807
|
$7,383,000 | — | 30 Jun 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
381,332
|
$7,222,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
320,014
|
$6,062,000 | — | 30 Jun 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
271,180
|
$5,136,000 | — | 30 Jun 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
259,439
|
$4,914,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
237,690
|
$4,502,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
235,734
|
$4,465,000 | — | 30 Jun 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1%
|
234,235
|
$4,436,000 | — | 30 Jun 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1%
|
231,006
|
$4,375,000 | — | 30 Jun 2020 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.98%
|
223,043
|
$4,224,000 | — | 30 Jun 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.88%
|
199,547
|
$3,780,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.8%
|
181,800
|
$3,443,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.8%
|
180,794
|
$3,425,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.79%
|
179,418
|
$3,398,000 | — | 30 Jun 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.74%
|
168,000
|
$3,182,000 | — | 30 Jun 2020 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.71%
|
161,822
|
$3,065,000 | — | 30 Jun 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.69%
|
156,782
|
$2,969,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.66%
|
149,178
|
$2,825,000 | — | 30 Jun 2020 | |
| QS Investors, LLC |
13F
|
Company |
0.64%
|
146,050
|
$2,767,000 | — | 30 Jun 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.64%
|
144,600
|
$2,739,000 | — | 30 Jun 2020 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q3 2020
As of 30 Sep 2020,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,150,667 shares.
The largest 10 holders included
BlackRock Inc., Avoro Capital Advisors LLC, Palo Alto Investors LP, STATE STREET CORP, FRONTIER CAPITAL MANAGEMENT CO LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., D. E. Shaw & Co., Inc., ALKEON CAPITAL MANAGEMENT LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
155
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
155
Q3 2020 holders
155
Holder diff
0
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.